These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2417016)

  • 21. Prolonged extracorporeal respiration with a membrane gas exchanger.
    Awad JA; Matte J; Brassard A
    J Thorac Cardiovasc Surg; 1973 Jul; 66(1):40-51. PubMed ID: 4715384
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin rebound in open heart surgery.
    Gollub S
    Surg Gynecol Obstet; 1967 Feb; 124(2):337-46. PubMed ID: 6016829
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of heparin therapy in open-heart surgery.
    Jaberi M; Bell WR; Benson DW
    J Thorac Cardiovasc Surg; 1974 Jan; 67(1):133-41. PubMed ID: 4808908
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation.
    Bull MH; Huse WM; Bull BS
    Anesthesiology; 1975 Sep; 43(3):346-53. PubMed ID: 1163834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heparinization--protaminization control by activated clotting time with improved postoperative hemostasis].
    Lubliner J; Barak J; Yakirevich V; Vidne BA
    Harefuah; 1984 Jul; 107(1-2):4-6. PubMed ID: 6479745
    [No Abstract]   [Full Text] [Related]  

  • 26. [Control of blood coagulation in extracorporeal circulation].
    Neef H
    Med Klin; 1971 Jan; 66(1):16-21. PubMed ID: 5545364
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications for transfusions of fresh blood in extracorporeal circulation in cardiac surgery].
    Jaulmes B; Viganò M
    Minerva Cardioangiol; 1967 Apr; 15(4):257-65. PubMed ID: 5613497
    [No Abstract]   [Full Text] [Related]  

  • 28. [Personal experience with monitoring the effects of heparin during cardiosurgical operations using artificial blood circulation].
    Sefránek V; Simkovic I; Barta E; Vrsanský D
    Bratisl Lek Listy; 1986 Mar; 85(3):305-14. PubMed ID: 3955413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin removal in three intraoperative blood savers in cardiac surgery.
    Rougé P; Fourquet D; Depoix-Joseph JP; Nguyen F; Barthélémy R
    Appl Cardiopulm Pathophysiol; 1993; 5(1):5-8. PubMed ID: 10171977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
    Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of blood heparin levels--variation in results with assay method.
    Juhan-Vague I; Riera H; Aillaud MF; Verdet D; Sambuc R
    Thromb Haemost; 1982 Jun; 47(3):295. PubMed ID: 7112503
    [No Abstract]   [Full Text] [Related]  

  • 33. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin levels and activated clotting time (ACT) during open heart surgery.
    Stenbjerg S; Berg E; Albrechtsen OK
    Scand J Haematol; 1981 Apr; 26(4):281-4. PubMed ID: 7336144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass.
    Porter JM; Silver D
    J Thorac Cardiovasc Surg; 1968 Dec; 56(6):869-78. PubMed ID: 5722114
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of GBH-coated Tygon tubing for experimental prolonged perfusions without systemic heparinization.
    Indeglia RA; Dorman FD; Castaneda AR; Varco RL; Bernstein EF
    Trans Am Soc Artif Intern Organs; 1966; 12():166-73. PubMed ID: 5960696
    [No Abstract]   [Full Text] [Related]  

  • 37. [Surgery under heparin. 3. Incomplete progressive neutralization of heparin at the end of extracorporeal circulation].
    Baille Y; Blanc T; Monties JR; Cohen M; Serra P; Jaquenoud P; Henry E
    Agressologie; 1970; 11(1):87-93. PubMed ID: 5423762
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early thrombocytopenia in artificial circulation].
    Traskunova NV; Voshnov VA; Kalenik LI
    Vestn Khir Im I I Grek; 1980 Sep; 125(9):101-4. PubMed ID: 7423802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 40. Transfusion of fresh autologous blood in open-heart surgery. A method for reducing bank blood requirements.
    Hallowell P; Bland JH; Buckley MJ; Lowenstein E
    J Thorac Cardiovasc Surg; 1972 Dec; 64(6):941-8. PubMed ID: 4636011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.